Leflunomide | m-entrepreneurship.com

Product Name :
Leflunomide

Search keywords :
Leflunomide

drugId :
null

Target Vo:
Dihydroorotate dehydrogenase

Target Vo Short Name :
DHODH

Moa_Name:
Dihydroorotate dehydrogenase inhibitors

First Approval Country :
United States

First Approval Date Filter:
1998

Origin Company_Name :
Sanofi

Active Company_Name :
INTERNATIONAL BIO SERVICES CO LTD

Active Indication_Name:
Arthritis, Rheumatoid

In Active Indication_Name:
HIV Infections

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Chk2 Rabbit mAb custom synthesis
PI 3 Kinase p85 alpha Rabbit mAb Technical Information
LAMP2a Antibody: LAMP2a Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 45 kDa, targeting to LAMP2a. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts